Cite
HARVARD Citation
Li, C. et al. (2023). Population pharmacokinetics and exposure–response of trilaciclib in extensive‐stage small cell lung cancer and triple‐negative breast cancer. British journal of clinical pharmacology. 89 (3), pp. 1067-1079. [Online].